Cells derived from iPSC can be immunogenic -- Yes or No
The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without...
Saved in:
Published in | Protein & cell Vol. 5; no. 1; pp. 1 - 3 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Beijing
Higher Education Press
2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syn- geneic iPSC-derived cells can be immunogenic in syn- geneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ lay- ers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negli- gible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergenUy required for translation of iPSC technology to clinics. |
---|---|
AbstractList | The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syngeneic iPSC-derived cells can be immunogenic in syngeneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ layers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negligible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergently required for translation of iPSC technology to clinics.The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syngeneic iPSC-derived cells can be immunogenic in syngeneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ layers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negligible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergently required for translation of iPSC technology to clinics. The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syngeneic iPSC-derived cells can be immunogenic in syngeneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ layers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negligible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergently required for translation of iPSC technology to clinics. The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syn- geneic iPSC-derived cells can be immunogenic in syn- geneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ lay- ers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negli- gible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergenUy required for translation of iPSC technology to clinics. The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syngeneic iPSC-derived cells can be immunogenic in syngeneic hosts by using a teratoma transplantation model (Nature 474:212–215, 2011 ). Recently two research groups differentiated the iPSCs into different germ layers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either “negligible” or “lack of” immunogenicity in iPSC derivatives (Nature 494:100–104, 2013 ; Cell Stem Cell 12:407–412, 2013 ). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergently required for translation of iPSC technology to clinics. |
Author | Lu, Xiao Cao, Jiani Yu, Honghao Zhang, Chao Zhao, Tongbiao Li, Xiaoyan |
AuthorAffiliation | State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China |
Author_xml | – sequence: 1 givenname: Jiani surname: Cao fullname: Cao, Jiani organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China – sequence: 2 givenname: Xiaoyan surname: Li fullname: Li, Xiaoyan organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China – sequence: 3 givenname: Xiao surname: Lu fullname: Lu, Xiao organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China – sequence: 4 givenname: Chao surname: Zhang fullname: Zhang, Chao organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China – sequence: 5 givenname: Honghao surname: Yu fullname: Yu, Honghao organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China – sequence: 6 givenname: Tongbiao surname: Zhao fullname: Zhao, Tongbiao email: tbzhao@ioz.ac.cn organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24474200$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk1v1DAUtFArWkp_ABdkblxC_ZXYuSChVfmQqoIESHCyHOc56yqxt3ZSiX9Poiwr6GE52ZJn5s288TN0EmIAhF5Q8oYSIq8y5YyrglBeEEJ4wZ6gc1pJUShC1cnhTn6cocuc78gC4rSs5FN0xoSQghFyjuQG-j7jFpJ_gBa7FAfsv3zdYGsCbgD7YZhC7CB4i4sC_4SMY8K38Tk6dabPcLk_L9D399ffNh-Lm88fPm3e3RS2LMlYVE1d8dopKSvFG-WqVpDKSVUa1oi2JkI2glFWOccdt61UDQPbWqO44k6Qhl-gt6vubmoGaC2EMZle75IfTPqlo_H635fgt7qLD5rXXKmSzQKv9wIp3k-QRz34bOfQJkCcsqZSVKqWoi7_Dy2JoCUt2QJ9-betg58_i50BdAXYFHNO4A4QSvTSn17703N_eqlGL1blI471oxl9XJL5_iiTrcw8TwkdJH0XpxTmYo6S1Era-m4LCdpdgpz1_AXC6CEdp77aO93G0N3PIw_xRE1rTjnnvwEQ4siw |
CitedBy_id | crossref_primary_10_1016_j_cjca_2014_06_023 crossref_primary_10_2217_fca_2016_0071 crossref_primary_10_3390_cells11030529 crossref_primary_10_4252_wjsc_v15_i5_453 crossref_primary_10_1101_cshperspect_a029561 crossref_primary_10_1007_s11427_016_0114_9 crossref_primary_10_3390_ijms22020958 crossref_primary_10_1038_celldisc_2015_15 crossref_primary_10_1186_s12938_019_0691_9 crossref_primary_10_4103_1673_5374_150638 crossref_primary_10_3389_fimmu_2014_00439 crossref_primary_10_1160_TH14_05_0480 crossref_primary_10_1007_s10741_016_9576_1 crossref_primary_10_3233_BPL_170055 crossref_primary_10_1111_imm_12722 crossref_primary_10_3390_ijms21093077 crossref_primary_10_1134_S1990747816010074 crossref_primary_10_1096_fj_202402790R crossref_primary_10_1186_s13287_015_0167_1 crossref_primary_10_1016_j_addr_2015_06_005 crossref_primary_10_1002_stem_2752 crossref_primary_10_3402_arb_v2_27144 crossref_primary_10_1038_s41536_021_00183_7 crossref_primary_10_1371_journal_pone_0106110 crossref_primary_10_1038_srep29955 crossref_primary_10_1038_cdd_2017_90 crossref_primary_10_3390_ijms21124384 crossref_primary_10_1007_s00441_019_03161_0 crossref_primary_10_1038_cddis_2014_205 crossref_primary_10_1186_s13287_022_03181_8 crossref_primary_10_1007_s00005_016_0385_y crossref_primary_10_3390_cells13121045 crossref_primary_10_1016_j_cellimm_2018_03_006 crossref_primary_10_4137_BMI_S20313 crossref_primary_10_1002_JLB_5BT0420_585RR crossref_primary_10_1007_s11892_017_0901_4 crossref_primary_10_1007_s12015_017_9790_9 crossref_primary_10_1186_s13045_014_0050_z crossref_primary_10_1002_med_21839 crossref_primary_10_1089_scd_2014_0151 |
Cites_doi | 10.1093/ajcp/82.1.115 10.1038/nature09798 10.1634/stemcells.2007-0151 10.1038/ng.471 10.1038/nbt.1667 10.1038/nature10135 10.1016/j.tcb.2009.12.004 10.1038/nature09342 10.1038/nature11807 10.1016/j.stem.2013.01.006 10.1097/00000658-198309000-00016 10.1016/j.cell.2006.07.024 10.1038/nature09805 |
ContentType | Journal Article |
Copyright | Copyright reserved, 2014, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The Author(s) 2014 |
Copyright_xml | – notice: Copyright reserved, 2014, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: The Author(s) 2014 |
DBID | 2RA 92L CQIGP ~WA C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 5PM |
DOI | 10.1007/s13238-013-0003-2 |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库- 镜像站点 Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Cells derived from iPSC can be immunogenic -- Yes or No |
EISSN | 1674-8018 |
EndPage | 3 |
ExternalDocumentID | PMC3938852 24474200 10_1007_s13238_013_0003_2 10.1007/s13238-013-0003-2 49193133 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -A0 0R~ 0VY 1-T 1N0 2JY 2RA 2VQ 30V 3V. 408 409 40D 53G 5VS 67N 7X7 88E 8AO 8FE 8FH 8FI 8FJ 92L AAFWJ AAKKN AAPXW AAVAP AAYZJ ABPTD ABUWG ACACY ACGFS ACPRK ADBBV ADINQ AENEX AFGXO AFKRA AFNRJ AFPKN AFWTZ AGJBK AHBXF AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BGNMA BHPHI BPHCQ BVXVI C24 C6C CAG CCPQU COF CQIGP DIK EBD EBS EMOBN F5P FYUFA GQ8 GROUPED_DOAJ HCIFZ HMCUK HMJXF HYE HZ~ I0C IPNFZ IZIGR KOV KQ8 LK8 M1P M4Y M7P NU0 O9- OJZSN OK1 P4S PIMPY PQQKQ PROAC PSQYO QOS R9I RIG ROX RPM RSV S27 S3A S3B SBL SCL SOJ SV3 T13 TOX TUS U2A UKHRP WK8 ~A9 ~WA ABXVV ACULB AAYZH ABEEZ ABEJV ABGNP ALIPV AMNDL H13 -SA -S~ AAXDM AAYXX ABFSG ACSTC AEZWR AFHIU AHWEU AIXLP CAJEA CITATION PHGZM PHGZT Q-- TGP U1G U5K CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7X8 7T5 H94 5PM |
ID | FETCH-LOGICAL-c550t-6b9639f877683b8f6d406f785a2b4d9047b42126ff3f3cd78b2ecdca8383f40b3 |
IEDL.DBID | C6C |
ISSN | 1674-800X 1674-8018 |
IngestDate | Thu Aug 21 18:25:50 EDT 2025 Fri Jul 11 05:31:28 EDT 2025 Mon Jul 21 10:35:15 EDT 2025 Mon Jul 21 06:05:26 EDT 2025 Tue Jul 01 03:08:02 EDT 2025 Thu Apr 24 22:56:17 EDT 2025 Fri Feb 21 02:33:12 EST 2025 Tue Feb 27 04:43:01 EST 2024 Wed Feb 14 10:37:30 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Immune Rejection Pluripotent Stem Cell Teratoma Autologous Cell iPSC |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://www.springer.com/tdm This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c550t-6b9639f877683b8f6d406f785a2b4d9047b42126ff3f3cd78b2ecdca8383f40b3 |
Notes | The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syn- geneic iPSC-derived cells can be immunogenic in syn- geneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ lay- ers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negli- gible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergenUy required for translation of iPSC technology to clinics. 11-5886/Q ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.1007/s13238-013-0003-2 |
PMID | 24474200 |
PQID | 1504151525 |
PQPubID | 23479 |
PageCount | 3 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3938852 proquest_miscellaneous_1746897495 proquest_miscellaneous_1504151525 pubmed_primary_24474200 crossref_primary_10_1007_s13238_013_0003_2 crossref_citationtrail_10_1007_s13238_013_0003_2 springer_journals_10_1007_s13238_013_0003_2 higheredpress_frontiers_10_1007_s13238_013_0003_2 chongqing_primary_49193133 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014 20140100 2014-1-00 2014-Jan 20140101 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – year: 2014 text: 2014 |
PublicationDecade | 2010 |
PublicationPlace | Beijing |
PublicationPlace_xml | – name: Beijing – name: Germany |
PublicationTitle | Protein & cell |
PublicationTitleAbbrev | Protein Cell |
PublicationTitleAlternate | Protein & Cell |
PublicationYear | 2014 |
Publisher | Higher Education Press |
Publisher_xml | – name: Higher Education Press |
References | GoreALiZFungHLYoungJEAgarwalSNature2011471636710.1038/nature098051:CAS:528:DC%2BC3MXis1CrsLg%3D, 3074107, 21368825, 10.1038/nature09805 TapperDLackEEAnn Surg198319839841010.1097/00000658-198309000-000161:STN:280:DyaL3szgslKhsA%3D%3D, 1353316, 6684416, 10.1097/00000658-198309000-00016 ListerRPelizzolaMKidaYSHawkinsRDNeryJRNature2011471687310.1038/nature097981:CAS:528:DC%2BC3MXhsVWjt78%3D, 3100360, 21289626, 10.1038/nature09798 KochCAGeraldesPPlattJLStem Cells200826899810.1634/stemcells.2007-01511:CAS:528:DC%2BD1cXhvVCktL4%3D, 17962705, 10.1634/stemcells.2007-0151 ArakiRUdaMHokiYSunayamaMNakamuraMNature201349410010410.1038/nature118071:CAS:528:DC%2BC3sXhtFSnt70%3D, 23302801, 10.1038/nature11807 TakahashiKYamanakaSCell200612666367610.1016/j.cell.2006.07.0241:CAS:528:DC%2BD28Xpt1aktbs%3D, 16904174, 10.1016/j.cell.2006.07.024 ChiJGLeeYSParkYSChangKYAm J Clin Pathol1984821151191:STN:280:DyaL2c3ltlKhsA%3D%3D, 6540049 ZhaoTZhangZNRongZXuYNature201147421221510.1038/nature101351:CAS:528:DC%2BC3MXntFKktLo%3D, 21572395, 10.1038/nature10135 PoloJMLiuSFigueroaMEKulalertWEminliSNat Biotechnol20102884885510.1038/nbt.16671:CAS:528:DC%2BC3cXovFOns7c%3D, 3148605, 20644536, 10.1038/nbt.1667 KimKDoiAWenBNgKZhaoRNature201046728529010.1038/nature093421:CAS:528:DC%2BC3cXhtFOht7rJ, 3150836, 20644535, 10.1038/nature09342 ZhaoTXuYTrends Cell Biol20102017017510.1016/j.tcb.2009.12.0041:CAS:528:DC%2BC3cXisFemu7o%3D, 20061153, 10.1016/j.tcb.2009.12.004 DoiAParkIHWenBMurakamiPAryeeMJNat Genet2009411350135310.1038/ng.4711:CAS:528:DC%2BD1MXhtlers7rM, 2958040, 19881528, 10.1038/ng.471 GuhaPMorganJWMostoslavskyGRodriguesNPBoydASCell Stem Cell20131240741210.1016/j.stem.2013.01.0061:CAS:528:DC%2BC3sXhsFGjsbw%3D, 23352605, 10.1016/j.stem.2013.01.006 D Tapper (3_CR11) 1983; 198 CA Koch (3_CR7) 2008; 26 K Takahashi (3_CR10) 2006; 126 K Kim (3_CR6) 2010; 467 R Lister (3_CR8) 2011; 471 P Guha (3_CR5) 2013; 12 T Zhao (3_CR12) 2010; 20 A Gore (3_CR4) 2011; 471 JG Chi (3_CR2) 1984; 82 JM Polo (3_CR9) 2010; 28 R Araki (3_CR1) 2013; 494 T Zhao (3_CR13) 2011; 474 A Doi (3_CR3) 2009; 41 20644536 - Nat Biotechnol. 2010 Aug;28(8):848-55 20061153 - Trends Cell Biol. 2010 Mar;20(3):170-5 19881528 - Nat Genet. 2009 Dec;41(12):1350-3 23302801 - Nature. 2013 Feb 7;494(7435):100-4 23352605 - Cell Stem Cell. 2013 Apr 4;12(4):407-12 20644535 - Nature. 2010 Sep 16;467(7313):285-90 17962705 - Stem Cells. 2008 Jan;26(1):89-98 21368825 - Nature. 2011 Mar 3;471(7336):63-7 21289626 - Nature. 2011 Mar 3;471(7336):68-73 21572395 - Nature. 2011 Jun 9;474(7350):212-5 16904174 - Cell. 2006 Aug 25;126(4):663-76 6684416 - Ann Surg. 1983 Sep;198(3):398-410 6540049 - Am J Clin Pathol. 1984 Jul;82(1):115-9 |
References_xml | – reference: ChiJGLeeYSParkYSChangKYAm J Clin Pathol1984821151191:STN:280:DyaL2c3ltlKhsA%3D%3D, 6540049 – reference: TakahashiKYamanakaSCell200612666367610.1016/j.cell.2006.07.0241:CAS:528:DC%2BD28Xpt1aktbs%3D, 16904174, 10.1016/j.cell.2006.07.024 – reference: ZhaoTZhangZNRongZXuYNature201147421221510.1038/nature101351:CAS:528:DC%2BC3MXntFKktLo%3D, 21572395, 10.1038/nature10135 – reference: ArakiRUdaMHokiYSunayamaMNakamuraMNature201349410010410.1038/nature118071:CAS:528:DC%2BC3sXhtFSnt70%3D, 23302801, 10.1038/nature11807 – reference: DoiAParkIHWenBMurakamiPAryeeMJNat Genet2009411350135310.1038/ng.4711:CAS:528:DC%2BD1MXhtlers7rM, 2958040, 19881528, 10.1038/ng.471 – reference: GoreALiZFungHLYoungJEAgarwalSNature2011471636710.1038/nature098051:CAS:528:DC%2BC3MXis1CrsLg%3D, 3074107, 21368825, 10.1038/nature09805 – reference: GuhaPMorganJWMostoslavskyGRodriguesNPBoydASCell Stem Cell20131240741210.1016/j.stem.2013.01.0061:CAS:528:DC%2BC3sXhsFGjsbw%3D, 23352605, 10.1016/j.stem.2013.01.006 – reference: ZhaoTXuYTrends Cell Biol20102017017510.1016/j.tcb.2009.12.0041:CAS:528:DC%2BC3cXisFemu7o%3D, 20061153, 10.1016/j.tcb.2009.12.004 – reference: KochCAGeraldesPPlattJLStem Cells200826899810.1634/stemcells.2007-01511:CAS:528:DC%2BD1cXhvVCktL4%3D, 17962705, 10.1634/stemcells.2007-0151 – reference: ListerRPelizzolaMKidaYSHawkinsRDNeryJRNature2011471687310.1038/nature097981:CAS:528:DC%2BC3MXhsVWjt78%3D, 3100360, 21289626, 10.1038/nature09798 – reference: TapperDLackEEAnn Surg198319839841010.1097/00000658-198309000-000161:STN:280:DyaL3szgslKhsA%3D%3D, 1353316, 6684416, 10.1097/00000658-198309000-00016 – reference: KimKDoiAWenBNgKZhaoRNature201046728529010.1038/nature093421:CAS:528:DC%2BC3cXhtFOht7rJ, 3150836, 20644535, 10.1038/nature09342 – reference: PoloJMLiuSFigueroaMEKulalertWEminliSNat Biotechnol20102884885510.1038/nbt.16671:CAS:528:DC%2BC3cXovFOns7c%3D, 3148605, 20644536, 10.1038/nbt.1667 – volume: 82 start-page: 115 year: 1984 ident: 3_CR2 publication-title: Am J Clin Pathol doi: 10.1093/ajcp/82.1.115 – volume: 471 start-page: 68 year: 2011 ident: 3_CR8 publication-title: Nature doi: 10.1038/nature09798 – volume: 26 start-page: 89 year: 2008 ident: 3_CR7 publication-title: Stem Cells doi: 10.1634/stemcells.2007-0151 – volume: 41 start-page: 1350 year: 2009 ident: 3_CR3 publication-title: Nat Genet doi: 10.1038/ng.471 – volume: 28 start-page: 848 year: 2010 ident: 3_CR9 publication-title: Nat Biotechnol doi: 10.1038/nbt.1667 – volume: 474 start-page: 212 year: 2011 ident: 3_CR13 publication-title: Nature doi: 10.1038/nature10135 – volume: 20 start-page: 170 year: 2010 ident: 3_CR12 publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2009.12.004 – volume: 467 start-page: 285 year: 2010 ident: 3_CR6 publication-title: Nature doi: 10.1038/nature09342 – volume: 494 start-page: 100 year: 2013 ident: 3_CR1 publication-title: Nature doi: 10.1038/nature11807 – volume: 12 start-page: 407 year: 2013 ident: 3_CR5 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.01.006 – volume: 198 start-page: 398 year: 1983 ident: 3_CR11 publication-title: Ann Surg doi: 10.1097/00000658-198309000-00016 – volume: 126 start-page: 663 year: 2006 ident: 3_CR10 publication-title: Cell doi: 10.1016/j.cell.2006.07.024 – volume: 471 start-page: 63 year: 2011 ident: 3_CR4 publication-title: Nature doi: 10.1038/nature09805 – reference: 20061153 - Trends Cell Biol. 2010 Mar;20(3):170-5 – reference: 16904174 - Cell. 2006 Aug 25;126(4):663-76 – reference: 20644536 - Nat Biotechnol. 2010 Aug;28(8):848-55 – reference: 6684416 - Ann Surg. 1983 Sep;198(3):398-410 – reference: 21289626 - Nature. 2011 Mar 3;471(7336):68-73 – reference: 23302801 - Nature. 2013 Feb 7;494(7435):100-4 – reference: 23352605 - Cell Stem Cell. 2013 Apr 4;12(4):407-12 – reference: 21368825 - Nature. 2011 Mar 3;471(7336):63-7 – reference: 6540049 - Am J Clin Pathol. 1984 Jul;82(1):115-9 – reference: 20644535 - Nature. 2010 Sep 16;467(7313):285-90 – reference: 19881528 - Nat Genet. 2009 Dec;41(12):1350-3 – reference: 17962705 - Stem Cells. 2008 Jan;26(1):89-98 – reference: 21572395 - Nature. 2011 Jun 9;474(7350):212-5 |
SSID | ssj0000331567 |
Score | 2.1960838 |
Snippet | The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited... The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited... |
SourceID | pubmedcentral proquest pubmed crossref springer higheredpress chongqing |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1 |
SubjectTerms | Animals Biochemistry Biomedical and Life Sciences Cell Biology Cell Cycle Proteins - metabolism Cell Transplantation - methods Developmental Biology Discussion Graft Rejection - immunology Human Genetics Induced Pluripotent Stem Cells - immunology Induced Pluripotent Stem Cells - transplantation iPS Life Sciences Membrane Proteins - metabolism Mice, Knockout Protein Science Stem Cells Teratoma - immunology Teratoma - metabolism 体细胞 免疫原性 免疫排斥反应 免疫耐受 再生医学 多能干细胞 细胞分化 |
Title | Cells derived from iPSC can be immunogenic -- Yes or No |
URI | http://lib.cqvip.com/qk/71234X/201401/49193133.html https://journal.hep.com.cn/pac/EN/10.1007/s13238-013-0003-2 https://link.springer.com/article/10.1007/s13238-013-0003-2 https://www.ncbi.nlm.nih.gov/pubmed/24474200 https://www.proquest.com/docview/1504151525 https://www.proquest.com/docview/1746897495 https://pubmed.ncbi.nlm.nih.gov/PMC3938852 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fi9QwEA96hyCI-N89dYngk1JsmzRJn-QsdxyC66G3UJ9CkibuwtLq7Z7gmx_CT-gncab_ZM9jwZdC6aS0mUkyv0zmN4S8sEr6JHEissLyiCdeREYJHlnjuQqiykOOicLvZ-Jkzt-VWdmTRWMuzKX4_es1oCWGx60Y5j-zCGbb_SxhEqs0FKIYt1NixgCJtKVUhOQw78blEMO86i3IpLBo6i_fYH3YWpFuLdrjFb5qj6Fe5Xb-e3ryUgi1XZmO75DbvUtJDzsbuEuu-foeudEVmfxxn-SFX63WtAJT--4rivkkdHn6qaDQqdR6usQMkQbsaOno75-_6Ge_ps05nTVvHpD58dFZcRL1BRMiB0BjEwkLwykPSgKGYBa7GpbrIFVmUsurPObSYgBYhMACc5VUNvWuckYBTA08tuwh2aub2j8m1CiTClOZREkGEEwYgGUu5sE6w5C_ZkIOxg7UXztiDM1zcAcB9E5IPPSodj3VOFa8WOm_JMmoEA0Kweg30-mEvBybDK_bIZxsqUkHJHvA0uG72jwfVKlhBGFYxNS-uYAmGdIUYB2oHTKSCwXQKweZR536x88EB0lymGwmRG4ZxiiADN7bT-rlomXyZjlTKoNvezWYkO6nkB1_cvBf0k_ITfDxeLdr9JTsbc4v_DPwozZ2Sq7LUk7J_tuj2elHuCtSPm1H1bTdmYDr2YcSrvP08A90fhZK |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Ra9swEBajZbRQyra2W7p102BPKwY7UiT5aYzQkm1tGKyF9ElIstQEgt016aBv_RH7hfslu5PtlGwl0OecHEd3Ot2Xu_uOkA9WSZ9lTiRWWJ7wzIvEKMETazxXQRR5yLFR-HQoBuf866g3avq4Z221e5uSjJ76vtmNwfWSxGkEWFAFfnedA2TGOr5-0-IQ3S9jgEniUBUhOXjgdNRmMx96CnIqjKvy8id849LdtDWOhRa-iAWpDwWg_9dR_pNMjXfU8TOy3QSX9HNtDc_JE1--IE_rcZO3OyTv--l0Rgswul--oNhZQifff_QpbC-1nk6wV6QCi5o4-ufuN73wM1pd02H1aZecHx-d9QdJMzohcQA55omwcLDyoCSgCWZx0-HiDlL1TNfyIk-5tJgKFiGwwFwhle16VzijALAGnlq2R9bKqvSvCDXKdIUpTKYkAzAmDAA0l_JgnWHIZNMh-4sN1Fc1RYbmOQSGAH87JG13VLuGdBxnX0z1PV0yKkSDQjAPznS3Qz4ulrSPWyGcLalJB6R9wCHiq9a8b1Wp4SxhgsSUvrqBJT0kLMCJUCtkJBcKQFgOMi9r9S9eE0IlycHtdIhcMoyFAHJ5L39STsaR05vlTKkevNtha0K6cSYrfsn-o6TfkY3B2emJPvky_PaabELkx-v_kt6Qtfn1jT-A6Gpu38bT9Bc1jBbf |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZaxsxEBYloaVQQs_E6aVCn1qW7FqypH0KZVuTXibQBtwnoTM2mN00dgp964_oL-wvycxewW0w9HlHe2hG0nw7M98Q8tIqGbLMicQKyxOeBZEYJXhiTeAqCp_HHAuFP0_E0Qn_MB1N2z6nyy7bvQtJNjUNyNJUrg7OfDy4KnxjcNQkdWcCTK6CPXgbgEqG6KsQRf-TJWUM8EndYEVIDrtxOu0im9fdBfkVZlV5-h2evnZO3ZnVSRfB18mp1zmj_-ZU_hVYrc-r8V2y0zqa9E1jGffIjVDeJzeb1pM_H5C8CIvFknowwB_BU6wyofPjLwWFqaY20DnWjVRgXXNH__z6Tb-FJa3O6aQ6fEhOxu--FkdJ20YhcQA_VomwsMjyqCQgC2ZRAXCIR6lGZmi5z1MuLYaFRYwsMuelssPgvDMKwGvkqWWPyFZZlWGPUKPMUBhvMiUZADNhAKy5lEfrDENWmwHZ7ydQnzV0GZrn4CQCFB6QtJtR7VoCcuyDsdBX1MmoEA0KwZg408MBedUP6W63QThbU5OOSAGBDcU3jXnRqVLDusJgiSlDdQFDRkhegN2hNshILhQAshxkdhv1968JbpPksAUNiFwzjF4Aeb3Xr5TzWc3vzXKm1Aje7XVnQrrdWDZ8yf5_ST8nt47fjvWn95OPj8ltcAJ581vpCdlanV-Ep-BoreyzejFdAmyvG0I |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cells+derived+from+iPSC+can+be+immunogenic+-+Yes+or+No%3F&rft.jtitle=Protein+%26+cell&rft.au=Cao%2C+Jiani&rft.au=Li%2C+Xiaoyan&rft.au=Lu%2C+Xiao&rft.au=Zhang%2C+Chao&rft.date=2014&rft.pub=Higher+Education+Press&rft.issn=1674-800X&rft.eissn=1674-8018&rft.volume=5&rft.issue=1&rft.spage=1&rft.epage=3&rft_id=info:doi/10.1007%2Fs13238-013-0003-2&rft.externalDBID=n%2Fa&rft.externalDocID=10.1007%2Fs13238-013-0003-2 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F71234X%2F71234X.jpg |